Genetics-testing company 23andMe has lost almost a third of its value over the past week as former investors and board members, including Sequoia Capital, sold shares in the once much-hyped Silicon Valley group.
過去一週，基因檢測公司23andMe的價值下跌了近三分之一，包括紅杉資本在內的前投資者和董事會成員出售了這家曾經被熱捧的矽谷集團的股票。
您已閱讀6%（279字），剩餘94%（4585字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。